Page 2 - Michaelf Brigham News Today

22.02.2022 - Annual Product Sales for 2021 Increased 25% over 2020PORTLAND, Maine, Feb. 22, 2022 (GLOBE NEWSWIRE) - ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets ...

the First Quarter Ended March 31, 2021 For Immediate Release PORTLAND, Maine - May 6, 2021 - ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2021 after the market closes on Thursday, May...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ImmuCell Closes $4,250,000 Equity Financing ImmuCell CorporationApril 14, 2021 GMT PORTLAND, Maine, April 14, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today an...

By Staff ImmuCell Corp. (Nasdaq: ICCC), a Portland biotech company that makes preventive health products for beef and dairy cattle, on Monday reported that sales revenue increased 12% in 2020, and has completed application for regulatory approval of a new product. Total sales grew by $1.6 million over the 2019 level to $15.3 million last year, the company said in a news release. Sales during the fourth quarter of 2020 were $3.7 million, up by $111,000, or 3%, from the same period ...

ImmuCell reports 2020 sales boost, new product update The Portland-based animal health company reported a 12% increase in sales and progress on its efforts to earn regulatory approval for a new product called Re-Tain. By STAFF REPORT Share ImmuCell Corp. reported a double-digit sales increase in 2020 and says it has made its last major submission to the U.S. Food and Drug Administration for a new product under development. The Portland-based animal health products maker, which produces immuni...

Share: PORTLAND, Maine, Dec. 15, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced a restructuring of its bank debt. Today, the Company secured a $1.5 million loan from its existing lender, Gorham Savings Bank, with a seven-year term and amortization a...